Results 101 to 110 of about 68,366 (207)
Atypical Antipsychotic Drugs Block Selective Components of Amphetamine-Induced Stereotypy
Individual items of behavior produced by 1.0 or 5.0 mg/kg d-amphetamine were monitored in rats pretreated 15 minutes earlier with vehicle or with behaviorally relevant doses of haloperidol (0.1 or 0.25 mg/kg), clozapine (1.0 or 5.0 mg/kg), or ...
Rebec, George V., Tschanz, JoAnn T.
core +1 more source
Amphetamine increased the response of rabbit aortic strips to adrenaline, dopamine and serotonin at consistently lower doses than those exerting a direct contracting effect.
PALMERY, Maura +3 more
core +1 more source
The clinical impact of recent amphetamine exposure in aneurysmal subarachnoid hemorrhage patients
BackgroundAmphetamines possess sympathomimetic properties that can affect cerebral vasculature though conflicting reports exist about their effect on vasospasm risk and clinical outcomes in aneurysmal subarachnoid hemorrhage.
Jeffrey R. Vitt +7 more
doaj +1 more source
PKCβ Inhibitors Attenuate Amphetamine-Stimulated Dopamine Efflux
Amphetamine abuse afflicts over 13 million people, and there is currently no universally accepted treatment for amphetamine addiction. Amphetamine serves as a substrate for the dopamine transporter and reverses the transporter to cause an increase in ...
Margaret E. Gnegy (2573395) +3 more
core +1 more source
Presumptive false-positive amphetamine urine screen in a pregnant woman receiving α-methyldopa: A case report. [PDF]
Sayer ÖN +3 more
europepmc +1 more source
People Seeking Treatment for Meth/Amphetamine Use Are Getting Older and Treatment Services Need to Adapt. [PDF]
Acheson LS +5 more
europepmc +1 more source
Patterns of Detecting Substances of Abuse in a Large Series of Patients in Spain During 2021-2025. [PDF]
Lara-Apolinario C +5 more
europepmc +1 more source
BIOPHARMACEUTIC ASPECTS OF DEUTERIO-AMPHETAMINE.
BIOPHARMACEUTIC ASPECTS OF DEUTERIO ...
RONALD LOUIS. FOREMAN (7984040)
core

